Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

Siebenhofer, A; Horvath, K; Kraly, B; Plank, J.
Diabetes and drug treatment of hypertension
Wien Med Wochenschr. 2003; 153(21-22): 464-468. Doi: 10.1007/s10354-003-0036-x
PubMed FullText FullText_MUG

Leading authors Med Uni Graz: Siebenhofer-Kroitzsch Andrea
Co-authors Med Uni Graz: Horvath Karl
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: In hypertensive diabetic patients, reducing blood pressure is among the best evaluated and most effective interventions for lowering mortality and morbidity. First line antihypertensive agents are: chlorthalidone or other thiazide-type diuretics, beta-blockers and ACE-inhibitors. In type 2 diabetic patients with left ventricular hypertrophy, the ARB Cosaar has been proven to be effective. To achieve an effective blood pressure reduction, a combination of different antihypertensive agents is necessary for most patients. Specially structured patient education programmes are another effective means of achieving this goal.
Find related publications in this database (using NLM MeSH Indexing): Adrenergic beta-Antagonists - adverse effects; Angiotensin-Converting Enzyme Inhibitors - adverse effects; Antihypertensive Agents - adverse effects; Benzothiadiazines - adverse effects; Cause of Death - adverse effects; Chlorthalidone - adverse effects; Diabetes Mellitus, Type 2 - drug therapy; Diuretics - drug therapy; Drug Therapy, Combination - drug therapy; Humans - drug therapy; Hypertension - drug therapy; Randomized Controlled Trials as Topic - drug therapy; Sodium Chloride Symporter Inhibitors - adverse effects; Survival Rate - adverse effects